Ulla Laine is a seasoned professional in the field of diabetes with extensive experience in the pharmaceutical industry. Ulla served as a Scientific Advisor at Bristol-Myers Squibb from May 2012 to January 2014 before transitioning to AstraZeneca in February 2014 as a Medical Advisor following AstraZeneca's acquisition of BMS's Diabetes business. Prior to this, Ulla worked as a Scientific Advisor and Product Specialist at Pfizer from February 2010 to April 2012. Ulla holds a Master of Science degree in Clinical Nutrition from Kuopion yliopisto, earned between 1992 and 1997.
This person is not in the org chart
This person is not in any teams
This person is not in any offices